ArticleKidney diseases (Basel, Switzerland)2022

Therapeutic Effect of Extracellular Vesicles Derived from HIF Prolyl Hydroxylase Domain Enzyme Inhibitor-Treated Cells on Renal Ischemia/Reperfusion Injury.

Zhao-Ying Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.